Jennifer Carr
Family Medicine · Richmond, VANPI 1427061605
Payments from drug & device makers
Across 311 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$520
- Amarin Pharma, Inc.$319
- Lilly USA, LLC$296
- Merck$279
- Novo Nordisk$278
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,585100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 79 | $1,151 |
| Amgen | 39 | $520 |
| Amarin Pharma, Inc. | 18 | $319 |
| Lilly USA, LLC | 19 | $296 |
| Merck | 24 | $279 |
| Novo Nordisk | 20 | $278 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $153 |
| AstraZeneca | 11 | $151 |
| Esperion Therapeutics, Inc. | 6 | $104 |
| Pfizer | 6 | $100 |
| Boehringer Ingelheim | 6 | $98 |
| Biohaven Pharmaceuticals, Inc. | 5 | $98 |
| Kowa Pharmaceuticals America, Inc. | 6 | $80 |
| GSK | 5 | $79 |
| Amneal Pharmaceuticals LLC | 4 | $58 |
| Abbott | 3 | $55 |
| Astellas Pharma US Inc | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Sanofi Pasteur Inc. | 3 | $48 |
| Novartis | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Exact Sciences | 2 | $44 |
| IBSA Pharma Inc. | 2 | $30 |
| Eisai Inc. | 2 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Currax Pharmaceuticals LLC | 2 | $23 |
| Johnson & Johnson | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| Dermira, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Bayer | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Neos Therapeutics, LP | 1 | $11 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$4,585 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 42 | $423 |
| Rosuvastatin Calcium | 15 | $279 |
| Atorvastatin Calcium | 46 | $233 |
| Escitalopram Oxalate | 12 | $185 |
| Simvastatin | 11 | $126 |
| Montelukast Sodium | 17 | $112 |
| Amlodipine Besylate | 27 | $68 |
| Hydrochlorothiazide | 13 | $45 |
| Lisinopril | 12 | $43 |
| Fluoxetine Hcl | 11 | $35 |
| Metformin Hcl | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $58 | $42342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Richmond
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Banks TurnerRichmond$74K
- James FosterRichmond$27K
- George MaughanRichmond$21K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.